SPTX Seaport Therapeutics | 8/20/2026 | Reiterated Rating | $24.42 | $50.00 | Buy | $0.00 00.00% ROI | |
MBOT Microbot Medical | 8/19/2026 | Reiterated Rating | $1.47 | | Buy | $0.00 00.00% ROI | |
ACOG Alpha Cognition | 8/17/2026 | Boost Price Target | $8.79 | $20.00 | Buy | $0.00 00.00% ROI | |
CGTX Cognition Therapeutics | 8/13/2026 | Reiterated Rating | $1.04 | | Buy | $0.00 00.00% ROI | |
INO Inovio Pharmaceuticals | 8/13/2026 | Reiterated Rating | $0.77 | | Neutral | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 8/13/2026 | Boost Price Target | $17.23 | $50.00 | Buy | $0.00 00.00% ROI | |
CRVO CervoMed | 8/12/2026 | Reiterated Rating | $3.09 | | Buy | $0.00 00.00% ROI | |
SEPN Septerna | 8/12/2026 | Boost Price Target | $47.76 | $60.00 | Buy | $0.00 00.00% ROI | |
VNDA Vanda Pharmaceuticals | 8/10/2026 | Lower Price Target | $5.00 | $20.00 | Buy | $0.00 00.00% ROI | |
EBS Emergent Biosolutions | 8/10/2026 | Lower Price Target | $4.85 | $10.00 | Buy | $0.00 00.00% ROI | |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
RARE Ultragenyx Pharmaceutical | 8/10/2026 | Reiterated Rating | $25.91 | $50.00 | Buy | $0.00 00.00% ROI | |
URGN Urogen Pharma | 8/6/2026 | Boost Price Target | $46.43 | $75.00 | Buy | $0.00 00.00% ROI | |
SPTX Seaport Therapeutics | 8/4/2026 | Reiterated Rating | $20.65 | $50.00 | Buy | $0.00 00.00% ROI | |
BCPC Balchem | 8/3/2026 | Boost Price Target | $167.55 | $215.00 | Buy | $0.00 00.00% ROI | |
LBRX LB Pharmaceuticals | 8/3/2026 | Reiterated Rating | $40.08 | $45.00 | Buy | $0.00 00.00% ROI | |
MPLT Maplight Therapeutics | 7/28/2026 | Lower Price Target | $9.90 | $26.00 | Buy | $0.00 00.00% ROI | |
LBRX LB Pharmaceuticals | 7/24/2026 | Reiterated Rating | $34.62 | | Buy | $0.00 00.00% ROI | |
SLGL Sol-Gel Technologies | 7/20/2026 | Reiterated Rating | $83.20 | $110.00 | Buy | $0.00 00.00% ROI | |
AARD Aardvark Therapeutics | 7/20/2026 | Reiterated Rating | $5.86 | $6.00 | Neutral | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 7/20/2026 | Reiterated Rating | $19.68 | $45.00 | Buy | $0.00 00.00% ROI | |
BWAY Brainsway | 7/17/2026 | Reiterated Rating | $14.84 | $14.00 | Buy | $0.00 00.00% ROI | |
PMN Promis Neurosciences | 7/15/2026 | Reiterated Rating | $13.66 | | Buy | $0.00 00.00% ROI | |
SPTX Seaport Therapeutics | 7/15/2026 | Initiated Coverage | $20.44 | $50.00 | Buy | $0.00 00.00% ROI | |
SPTX Seaport Therapeutics | 7/15/2026 | Set Price Target | $20.44 | $50.00 | | $0.00 00.00% ROI | |
CRVO CervoMed | 7/15/2026 | Reiterated Rating | $3.08 | | Buy | $0.00 00.00% ROI | |
AXSM Axsome Therapeutics | 7/15/2026 | Reiterated Rating | $235.33 | $290.00 | Buy | $0.00 00.00% ROI | |
SPTX Seaport Therapeutics | 7/15/2026 | Initiated Coverage | $20.45 | $50.00 | Buy | $0.00 00.00% ROI | |
MBOT Microbot Medical | 7/14/2026 | Reiterated Rating | $1.88 | | Buy | $0.00 00.00% ROI | |
BBIO BridgeBio Pharma | 7/13/2026 | Boost Price Target | $85.89 | $120.00 | Buy | $0.00 00.00% ROI | |
URGN Urogen Pharma | 7/9/2026 | Reiterated Rating | $38.03 | | Buy | $0.00 00.00% ROI | |
RMTI Rockwell Medical | 7/9/2026 | Reiterated Rating | $5.63 | $20.00 | Buy | $0.00 00.00% ROI | |
CRVO CervoMed | 7/9/2026 | Reiterated Rating | $3.41 | | Buy | $0.00 00.00% ROI | |
PLYX Polaryx Therapeutics | 7/9/2026 | Initiated Coverage | $2.55 | $7.00 | Buy | $0.00 00.00% ROI | |
AXSM Axsome Therapeutics | 7/8/2026 | Reiterated Rating | $249.76 | $290.00 | Buy | $0.00 00.00% ROI | |
GMAB Genmab A/S | 7/2/2026 | Boost Price Target | $27.64 | $40.00 | Buy | $0.00 00.00% ROI | |
BWAY Brainsway | 7/2/2026 | Reiterated Rating | $15.29 | $17.00 | Buy | $0.00 00.00% ROI | |
LRMR Larimar Therapeutics | 7/2/2026 | Initiated Coverage | $3.21 | $10.00 | Buy | $0.00 00.00% ROI | |
NAGE Niagen Bioscience | 7/1/2026 | Reiterated Rating | $3.19 | | Buy | $0.00 00.00% ROI | |
GANX Gain Therapeutics | 7/1/2026 | Reiterated Rating | $2.03 | $8.00 | Buy | $0.00 00.00% ROI | |
SEPN Septerna | 7/1/2026 | Reiterated Rating | $33.49 | $40.00 | Buy | $0.00 00.00% ROI | |
The retirement stock I'd buy before Nvidia today (Ad) In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick.
The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names.
Chaikin lays out the full case in a new free presentation, no email or credit card required. Get Marc Chaikin's free presentation on this overlooked AI stock now |
ENTX Entera Bio | 6/24/2026 | Reiterated Rating | $1.55 | | Buy | $0.00 00.00% ROI | |
PMN Promis Neurosciences | 6/24/2026 | Reiterated Rating | $10.69 | $18.00 | Buy | $0.00 00.00% ROI | |
CLYM Climb Bio | 6/24/2026 | Reiterated Rating | $12.30 | $20.00 | Buy | $0.00 00.00% ROI | |
GMAB Genmab A/S | 6/23/2026 | Reiterated Rating | $25.61 | $38.00 | Buy | $0.00 00.00% ROI | |
LBRX LB Pharmaceuticals | 6/22/2026 | Reiterated Rating | $30.03 | | Buy | $0.00 00.00% ROI | |
MPLT Maplight Therapeutics | 6/22/2026 | Reiterated Rating | $28.82 | | Buy | $0.00 00.00% ROI | |
BWAY Brainsway | 6/15/2026 | Reiterated Rating | $14.63 | $17.00 | Buy | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 6/8/2026 | Reiterated Rating | $17.90 | $45.00 | Buy | $0.00 00.00% ROI | |
PMN Promis Neurosciences | 6/8/2026 | Reiterated Rating | $9.93 | $18.00 | Buy | $0.00 00.00% ROI | |
VNDA Vanda Pharmaceuticals | 6/4/2026 | Reiterated Rating | $6.09 | | Buy | $0.00 00.00% ROI | |
AXSM Axsome Therapeutics | 6/4/2026 | Reiterated Rating | $233.31 | | Buy | $0.00 00.00% ROI | |
URGN Urogen Pharma | 6/3/2026 | Reiterated Rating | $26.54 | $45.00 | Buy | $0.00 00.00% ROI | |
SPRB Spruce Biosciences | 6/1/2026 | Lower Price Target | $51.27 | $150.00 | Buy | $0.00 00.00% ROI | |
INO Inovio Pharmaceuticals | 6/1/2026 | Lower Price Target | $1.31 | $2.50 | Neutral | $0.00 00.00% ROI | |
INVA Innoviva | 6/1/2026 | Reiterated Rating | $21.42 | $46.00 | Buy | $0.00 00.00% ROI | |
BBIO BridgeBio Pharma | 5/28/2026 | Reiterated Rating | $66.44 | $110.00 | Buy | $0.00 00.00% ROI | |
ABEO Abeona Therapeutics | 5/28/2026 | Reiterated Rating | $5.69 | $20.00 | Buy | $0.00 00.00% ROI | |
MPLT Maplight Therapeutics | 5/28/2026 | Reiterated Rating | $29.55 | $45.00 | Buy | $0.00 00.00% ROI | |
LBRX LB Pharmaceuticals | 5/26/2026 | Reiterated Rating | $28.12 | | Buy | $0.00 00.00% ROI | |
BWAY Brainsway | 5/26/2026 | Reiterated Rating | $15.10 | $17.00 | Buy | $0.00 00.00% ROI | |
VRCA Verrica Pharmaceuticals | 5/26/2026 | Initiated Coverage | $6.06 | $12.00 | Buy | $0.00 00.00% ROI | |
CING Cingulate | 5/26/2026 | Reiterated Rating | $4.47 | $20.00 | Buy | $0.00 00.00% ROI | |
RMTI Rockwell Medical | 5/22/2026 | Reiterated Rating | $8.10 | $20.00 | Buy | $0.00 00.00% ROI | |
FENC Adherex Technologies | 5/22/2026 | Boost Price Target | $9.97 | $16.00 | Buy | $0.00 00.00% ROI | |
ACOG Alpha Cognition | 5/22/2026 | Reiterated Rating | $5.82 | $18.00 | Buy | $0.00 00.00% ROI | |
URGN Urogen Pharma | 5/18/2026 | Reiterated Rating | $28.78 | $45.00 | Buy | $0.00 00.00% ROI | |
SEPN Septerna | 5/13/2026 | Reiterated Rating | $24.84 | $40.00 | Buy | $0.00 00.00% ROI | |
CLYM Climb Bio | 5/12/2026 | Boost Price Target | $11.12 | $20.00 | Buy | $0.00 00.00% ROI | |
URGN Urogen Pharma | 5/11/2026 | Boost Price Target | $29.40 | $45.00 | Buy | $0.00 00.00% ROI | |
BBIO BridgeBio Pharma | 5/11/2026 | Boost Price Target | $67.39 | $110.00 | Buy | $0.00 00.00% ROI | |
NAGE Niagen Bioscience | 5/11/2026 | Lower Price Target | $4.17 | $11.00 | Buy | $0.00 00.00% ROI | |
VNDA Vanda Pharmaceuticals | 5/11/2026 | Lower Price Target | $6.28 | $21.00 | Buy | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 5/11/2026 | Boost Price Target | $17.06 | $45.00 | Buy | $0.00 00.00% ROI | |
TRDA Entrada Therapeutics | 5/8/2026 | Downgrade | $6.85 | | Neutral | $0.00 00.00% ROI | |
ASRT Assertio | 5/5/2026 | Reiterated Rating | $21.61 | $21.80 | Neutral | $0.00 00.00% ROI | |
AXSM Axsome Therapeutics | 5/5/2026 | Boost Price Target | $224.03 | $290.00 | Buy | $0.00 00.00% ROI | |
AXSM Axsome Therapeutics | 5/4/2026 | Boost Price Target | $206.53 | $270.00 | Buy | $0.00 00.00% ROI | |
MPLT Maplight Therapeutics | 5/4/2026 | Initiated Coverage | $30.70 | $45.00 | Buy | $0.00 00.00% ROI | |
LGVN Longeveron | 5/4/2026 | Lower Price Target | $0.85 | $8.00 | Buy | $0.00 00.00% ROI | |
MPLT Maplight Therapeutics | 5/4/2026 | Initiated Coverage | $28.61 | $45.00 | Buy | $0.00 00.00% ROI | |
GMAB Genmab A/S | 4/30/2026 | Lower Price Target | $26.11 | $38.00 | Buy | $0.00 00.00% ROI | |
NGEN NervGen Pharma | 4/28/2026 | Upgrade | $3.88 | | Strong-Buy | $0.00 00.00% ROI | |
LBRX LB Pharmaceuticals | 4/27/2026 | Initiated Coverage | $30.73 | $45.00 | Buy | $0.00 00.00% ROI | |
BBIO BridgeBio Pharma | 4/27/2026 | Reiterated Rating | $73.28 | $100.00 | Buy | $0.00 00.00% ROI | |
ENTX Entera Bio | 4/27/2026 | Lower Price Target | $1.12 | $9.00 | Buy | $0.00 00.00% ROI | |
ACOG Alpha Cognition | 4/27/2026 | Reiterated Rating | $6.86 | $18.00 | Buy | $0.00 00.00% ROI | |
LBRX LB Pharmaceuticals | 4/27/2026 | Upgrade | $31.81 | $45.00 | Strong-Buy | $0.00 00.00% ROI | |
CRVO CervoMed | 4/23/2026 | Reiterated Rating | $3.94 | $25.00 | Buy | $0.00 00.00% ROI | |
SEPN Septerna | 4/14/2026 | Reiterated Rating | $23.34 | $40.00 | Buy | $0.00 00.00% ROI | |
MBOT Microbot Medical | 4/14/2026 | Reiterated Rating | $2.35 | $12.00 | Buy | $0.00 00.00% ROI | |
Major Buy Alert Issued for August 31st (Ad) Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 people worldwide.
His system has flagged a handful of stocks worth watching ahead of August 31st.
See which stocks his AI research platform is flagging right now. See which stocks his AI research platform is flagging now |
OVID Ovid Therapeutics | 4/9/2026 | Boost Price Target | $2.60 | $4.00 | Buy | $0.00 00.00% ROI | |
ASRT Assertio | 4/9/2026 | Reiterated Rating | $18.41 | $18.00 | Neutral | $0.00 00.00% ROI | |
SLNO Soleno Therapeutics | 4/8/2026 | Downgrade | $52.35 | $53.00 | Hold | $0.00 00.00% ROI | |
ENLV Enlivex Therapeutics | 4/7/2026 | Boost Price Target | $13.10 | $300.00 | Buy | $0.00 00.00% ROI | |
BTAI BioXcel Therapeutics | 4/2/2026 | Lower Price Target | $1.22 | $5.00 | Buy | $0.00 00.00% ROI | |
RMTI Rockwell Medical | 3/30/2026 | Lower Price Target | $8.70 | $20.00 | Buy | $0.00 00.00% ROI | |
COYA Coya Therapeutics | 3/23/2026 | Reiterated Rating | $4.21 | $18.00 | Buy | $0.00 00.00% ROI | |
RGEN Repligen | 3/23/2026 | Boost Price Target | $113.88 | $208.00 | Buy | $0.00 00.00% ROI | |
ABEO Abeona Therapeutics | 3/19/2026 | Reiterated Rating | $4.55 | $20.00 | Buy | $0.00 00.00% ROI | |
PLX Protalix BioTherapeutics | 3/19/2026 | Reiterated Rating | $2.21 | $12.00 | Buy | $0.00 00.00% ROI | |
ACRS Aclaris Therapeutics | 3/19/2026 | Reiterated Rating | $3.66 | $16.00 | Buy | $0.00 00.00% ROI | |
RYTM Rhythm Pharmaceuticals | 3/18/2026 | Lower Price Target | $87.68 | $100.00 | Buy | $0.00 00.00% ROI | |
BWAY Brainsway | 3/12/2026 | Lower Price Target | $13.77 | $15.00 | Buy | $0.00 00.00% ROI | |
CLYM Climb Bio | 3/10/2026 | Boost Price Target | $7.25 | $15.00 | Buy | $0.00 00.00% ROI | |
SPRB Spruce Biosciences | 3/10/2026 | Reiterated Rating | $62.11 | $200.00 | Buy | $0.00 00.00% ROI | |
ABEO Abeona Therapeutics | 3/10/2026 | Reiterated Rating | $5.16 | $20.00 | Buy | $0.00 00.00% ROI | |
EBS Emergent Biosolutions | 3/9/2026 | Lower Price Target | $8.29 | $12.00 | Buy | $0.00 00.00% ROI | |
BNTC Benitec Biopharma | 3/9/2026 | Reiterated Rating | $12.82 | $32.00 | Buy | $0.00 00.00% ROI | |
BTAI BioXcel Therapeutics | 3/5/2026 | Lower Price Target | $1.67 | $6.00 | Buy | $0.00 00.00% ROI | |
SLNO Soleno Therapeutics | 3/4/2026 | Lower Price Target | $37.72 | $100.00 | Buy | $0.00 00.00% ROI | |
AARD Aardvark Therapeutics | 3/2/2026 | Reiterated Rating | $12.49 | | Neutral | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 3/2/2026 | Boost Price Target | $17.51 | $40.00 | Buy | $0.00 00.00% ROI | |
RYTM Rhythm Pharmaceuticals | 3/2/2026 | Lower Price Target | $92.73 | $110.00 | Buy | $0.00 00.00% ROI | |
SEPN Septerna | 3/2/2026 | Boost Price Target | $28.56 | $40.00 | Buy | $0.00 00.00% ROI | |
BCPC Balchem | 2/24/2026 | Reiterated Rating | $175.68 | $190.00 | Buy | $0.00 00.00% ROI | |
VNDA Vanda Pharmaceuticals | 2/23/2026 | Boost Price Target | $5.76 | $24.00 | Buy | $0.00 00.00% ROI | |
SPRB Spruce Biosciences | 2/19/2026 | Reiterated Rating | $53.48 | $200.00 | Buy | $0.00 00.00% ROI | |
TRDA Entrada Therapeutics | 2/18/2026 | Reiterated Rating | $11.02 | $20.00 | Buy | $0.00 00.00% ROI | |
GMAB Genmab A/S | 2/18/2026 | Boost Price Target | $30.00 | $40.00 | Buy | $0.00 00.00% ROI | |
RARE Ultragenyx Pharmaceutical | 2/17/2026 | Lower Price Target | $20.52 | $50.00 | Buy | $0.00 00.00% ROI | |
BBIO BridgeBio Pharma | 2/17/2026 | Boost Price Target | $75.25 | $100.00 | Buy | $0.00 00.00% ROI | |
AVXL Anavex Life Sciences | 2/10/2026 | Reiterated Rating | $4.35 | $20.00 | Buy | $0.00 00.00% ROI | |
AARD Aardvark Therapeutics | 2/9/2026 | Reiterated Rating | $12.65 | $40.00 | Buy | $0.00 00.00% ROI | |
ENTX Entera Bio | 2/9/2026 | Reiterated Rating | $1.04 | $10.00 | Buy | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 2/3/2026 | Reiterated Rating | $15.79 | $32.00 | Buy | $0.00 00.00% ROI | |
RARE Ultragenyx Pharmaceutical | 2/3/2026 | Reiterated Rating | $24.75 | $60.00 | Buy | $0.00 00.00% ROI | |
COYA Coya Therapeutics | 2/2/2026 | Reiterated Rating | $4.65 | $18.00 | Buy | $0.00 00.00% ROI | |
ACRS Aclaris Therapeutics | 1/28/2026 | Reiterated Rating | $3.87 | $16.00 | Buy | $0.00 00.00% ROI | |
GMAB Genmab A/S | 1/28/2026 | Reiterated Rating | $34.40 | $39.00 | Buy | $0.00 00.00% ROI | |
BWAY Brainsway | 1/26/2026 | Boost Price Target | $11.52 | $15.00 | Buy | $0.00 00.00% ROI | |
RMTI Rockwell Medical | 1/26/2026 | Reiterated Rating | $11.50 | $25.00 | Buy | $0.00 00.00% ROI | |
ACRS Aclaris Therapeutics | 1/21/2026 | Reiterated Rating | $4.43 | $16.00 | Buy | $0.00 00.00% ROI | |
SEPN Septerna | 1/20/2026 | Boost Price Target | $26.07 | $35.00 | Buy | $0.00 00.00% ROI | |
SLGL Sol-Gel Technologies | 1/20/2026 | Reiterated Rating | $69.50 | $110.00 | Buy | $0.00 00.00% ROI | |
SLNO Soleno Therapeutics | 1/20/2026 | Reiterated Rating | $42.48 | $120.00 | Buy | $0.00 00.00% ROI | |
RYTM Rhythm Pharmaceuticals | 1/20/2026 | Boost Price Target | $101.63 | $125.00 | Buy | $0.00 00.00% ROI | |
AXSM Axsome Therapeutics | 1/20/2026 | Boost Price Target | $177.27 | $260.00 | Buy | $0.00 00.00% ROI | |
GMAB Genmab A/S | 1/20/2026 | Lower Price Target | $32.25 | $39.00 | Buy | $0.00 00.00% ROI | |
ENLV Enlivex Therapeutics | 1/12/2026 | Boost Price Target | $13.53 | $195.00 | Buy | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 1/9/2026 | Reiterated Rating | $14.34 | $32.00 | Buy | $0.00 00.00% ROI | |
Buffett's Final Warning: "The Dollar Is Going to Hell" (Ad) The US just hit $39 trillion in debt. Interest alone is now over $1 trillion a year, more than the entire defense budget. There's no way to tax our way out. No way to cut our way out. The government has exactly one move left:
Pump trillions into AI to outgrow the debt. And the asset class profiting from these trillions in spending. BlackRock is buying. Goldman Sachs is buying. Gartner is calling it the next decade defining boom.
The last time a similar setup formed, early investors saw gains of up to 12,480%. I've put together a workshop breaking this down in detail. I'll name the asset class and show you exactly how to profit from this $39 trillion debt crisis. Click here to register for the free workshop → |
AXSM Axsome Therapeutics | 1/5/2026 | Boost Price Target | $178.69 | $200.00 | Buy | $0.00 00.00% ROI | |
ASRT Assertio | 1/5/2026 | Reiterated Rating | $9.14 | $35.00 | Buy | $0.00 00.00% ROI | |
VNDA Vanda Pharmaceuticals | 1/5/2026 | Boost Price Target | $8.25 | $22.00 | Buy | $0.00 00.00% ROI | |
RARE Ultragenyx Pharmaceutical | 1/5/2026 | Lower Price Target | $23.29 | $60.00 | Buy | $0.00 00.00% ROI | |
INO Inovio Pharmaceuticals | 12/30/2025 | Reiterated Rating | $1.73 | | Neutral | $0.00 00.00% ROI | |
IKT Inhibikase Therapeutics | 12/26/2025 | Reiterated Rating | $1.74 | $8.00 | Buy | $0.00 00.00% ROI | |
RVPH Reviva Pharmaceuticals | 12/23/2025 | Reiterated Rating | $6.43 | $80.00 | Buy | $0.00 00.00% ROI | |
RYTM Rhythm Pharmaceuticals | 12/22/2025 | Boost Price Target | $112.14 | $123.00 | Buy | $0.00 00.00% ROI | |
OVID Ovid Therapeutics | 12/22/2025 | Reiterated Rating | $1.47 | $2.00 | Buy | $0.00 00.00% ROI | |
SPRB Spruce Biosciences | 12/22/2025 | Reiterated Rating | $78.74 | $220.00 | Buy | $0.00 00.00% ROI | |
SLGL Sol-Gel Technologies | 12/22/2025 | Reiterated Rating | $42.16 | $50.00 | Buy | $0.00 00.00% ROI | |
AVXL Anavex Life Sciences | 12/19/2025 | Reiterated Rating | $3.67 | $20.00 | Buy | $0.00 00.00% ROI | |
GANX Gain Therapeutics | 12/19/2025 | Reiterated Rating | $2.25 | $8.00 | Buy | $0.00 00.00% ROI | |
ACOG Alpha Cognition | 12/19/2025 | Reiterated Rating | $5.05 | $18.00 | Buy | $0.00 00.00% ROI | |
CLYM Climb Bio | 12/18/2025 | Boost Price Target | $4.25 | $11.00 | Buy | $0.00 00.00% ROI | |
CRVO CervoMed | 12/18/2025 | Reiterated Rating | $7.99 | $25.00 | Buy | $0.00 00.00% ROI | |
INVA Innoviva | 12/16/2025 | Boost Price Target | $20.14 | $46.00 | Buy | $0.00 00.00% ROI | |
EBS Emergent Biosolutions | 12/16/2025 | Reiterated Rating | $12.35 | $15.00 | Buy | $0.00 00.00% ROI | |
BWAY Brainsway | 12/8/2025 | Boost Price Target | $8.64 | $12.00 | Buy | $0.00 00.00% ROI | |
CGTX Cognition Therapeutics | 12/4/2025 | Reiterated Rating | $1.80 | $3.00 | Buy | $0.00 00.00% ROI | |
PMN Promis Neurosciences | 12/1/2025 | Reiterated Rating | $6.54 | $18.00 | Buy | $0.00 00.00% ROI | |
GANX Gain Therapeutics | 12/1/2025 | Reiterated Rating | $3.58 | $8.00 | Buy | $0.00 00.00% ROI | |
VNDA Vanda Pharmaceuticals | 12/1/2025 | Reiterated Rating | $5.36 | | Buy | $0.00 00.00% ROI | |
MBOT Microbot Medical | 11/28/2025 | Reiterated Rating | $2.29 | $12.00 | Buy | $0.00 00.00% ROI | |
AVXL Anavex Life Sciences | 11/28/2025 | Reiterated Rating | $3.86 | | Buy | $0.00 00.00% ROI | |
COYA Coya Therapeutics | 11/24/2025 | Reiterated Rating | $5.98 | | Buy | $0.00 00.00% ROI | |
OVID Ovid Therapeutics | 11/24/2025 | Boost Price Target | $1.40 | $2.00 | Buy | $0.00 00.00% ROI | |
BNTC Benitec Biopharma | 11/24/2025 | Set Price Target | $13.26 | $32.00 | Buy | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 11/21/2025 | Lower Price Target | $13.00 | $26.00 | Buy | $0.00 00.00% ROI | |
PLX Protalix BioTherapeutics | 11/21/2025 | Lower Price Target | $1.74 | $12.00 | Buy | $0.00 00.00% ROI | |
PMN Promis Neurosciences | 11/21/2025 | Reiterated Rating | $9.55 | $100.00 | Buy | $0.00 00.00% ROI | |
CGTX Cognition Therapeutics | 11/19/2025 | Reiterated Rating | $1.52 | $3.00 | Buy | $0.00 00.00% ROI | |
VNDA Vanda Pharmaceuticals | 11/19/2025 | Reiterated Rating | $5.35 | $20.00 | Buy | $0.00 00.00% ROI | |
RMTI Rockwell Medical | 11/13/2025 | Lower Price Target | $9.25 | $25.00 | Buy | $0.00 00.00% ROI | |
BWAY Brainsway | 11/13/2025 | Boost Price Target | $7.95 | $9.00 | Buy | $0.00 00.00% ROI | |
SEPN Septerna | 11/11/2025 | Boost Price Target | $18.10 | $30.00 | Buy | $0.00 00.00% ROI | |
GMAB Genmab A/S | 11/10/2025 | Boost Price Target | $28.66 | $41.00 | Buy | $0.00 00.00% ROI | |
CRVO CervoMed | 11/5/2025 | Upgrade | $7.02 | $25.00 | Buy | $0.00 00.00% ROI | |
AXSM Axsome Therapeutics | 11/4/2025 | Boost Price Target | $133.96 | $185.00 | Buy | $0.00 00.00% ROI | |
BNTC Benitec Biopharma | 11/4/2025 | Boost Price Target | $15.66 | $35.00 | Buy | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 11/3/2025 | Upgrade | $10.10 | $30.00 | Buy | $0.00 00.00% ROI | |
BBIO BridgeBio Pharma | 11/3/2025 | Reiterated Rating | $62.64 | $90.00 | Buy | $0.00 00.00% ROI | |
GMAB Genmab A/S | 10/27/2025 | Reiterated Rating | $29.46 | | Buy | $0.00 00.00% ROI | |
URGN Urogen Pharma | 10/27/2025 | Reiterated Rating | $19.82 | $40.00 | Buy | $0.00 00.00% ROI | |
BBIO BridgeBio Pharma | 10/27/2025 | Boost Price Target | $63.56 | $80.00 | Buy | $0.00 00.00% ROI | |
SLGL Sol-Gel Technologies | 10/27/2025 | Boost Price Target | $40.70 | $50.00 | Buy | $0.00 00.00% ROI | |
RVPH Reviva Pharmaceuticals | 10/27/2025 | Lower Price Target | $13.51 | $80.00 | Buy | $0.00 00.00% ROI | |
AVDL Avadel Pharmaceuticals | 10/23/2025 | Downgrade | $18.52 | $20.00 | Neutral | $0.00 00.00% ROI | |
BCPC Balchem | 10/22/2025 | Boost Price Target | $156.89 | $190.00 | Buy | $0.00 00.00% ROI | |
ACOG Alpha Cognition | 10/20/2025 | Lower Price Target | $6.80 | $18.00 | Buy | $0.00 00.00% ROI | |
Why major institutions are piling into this digital asset now (Ad) BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid.
The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. Get the name, the ticker, and exactly how to buy it |
ACRS Aclaris Therapeutics | 10/20/2025 | Reiterated Rating | $1.90 | $16.00 | Buy | $0.00 00.00% ROI | |
MBOT Microbot Medical | 10/15/2025 | Reiterated Rating | $2.88 | $12.00 | Buy | $0.00 00.00% ROI | |
GMAB Genmab A/S | 10/15/2025 | Reiterated Rating | $32.75 | $40.00 | Buy | $0.00 00.00% ROI | |
CLYM Climb Bio | 10/13/2025 | Initiated Coverage | $1.80 | $9.00 | Buy | $0.00 00.00% ROI | |
ABEO Abeona Therapeutics | 10/13/2025 | Reiterated Rating | $5.36 | $20.00 | Buy | $0.00 00.00% ROI | |
GANX Gain Therapeutics | 10/13/2025 | Reiterated Rating | $1.97 | $8.00 | Buy | $0.00 00.00% ROI | |
CLYM Climb Bio | 10/13/2025 | Initiated Coverage | $2.00 | $9.00 | Buy | $0.00 00.00% ROI | |
AVXL Anavex Life Sciences | 10/7/2025 | Reiterated Rating | $9.61 | $42.00 | Buy | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 10/2/2025 | Downgrade | $7.06 | | Neutral | $0.00 00.00% ROI | |
GMAB Genmab A/S | 10/2/2025 | Boost Price Target | $31.88 | $40.00 | Buy | $0.00 00.00% ROI | |
RYTM Rhythm Pharmaceuticals | 9/29/2025 | Boost Price Target | $99.16 | $110.00 | Buy | $0.00 00.00% ROI | |
AARD Aardvark Therapeutics | 9/23/2025 | Reiterated Rating | $11.23 | $40.00 | Buy | $0.00 00.00% ROI | |
BTAI BioXcel Therapeutics | 9/15/2025 | Reiterated Rating | $3.11 | $10.00 | Buy | $0.00 00.00% ROI | |
BBIO BridgeBio Pharma | 9/15/2025 | Reiterated Rating | $51.21 | $70.00 | Buy | $0.00 00.00% ROI | |
MBOT Microbot Medical | 9/11/2025 | Boost Price Target | $3.57 | $12.00 | Buy | $0.00 00.00% ROI | |
AVXL Anavex Life Sciences | 9/10/2025 | Reiterated Rating | $9.13 | $42.00 | Buy | $0.00 00.00% ROI | |
RARE Ultragenyx Pharmaceutical | 9/9/2025 | Reiterated Rating | $31.51 | $80.00 | Buy | $0.00 00.00% ROI | |
CRVO CervoMed | 9/8/2025 | Reiterated Rating | $10.51 | $11.00 | Neutral | $0.00 00.00% ROI | |
AVDL Avadel Pharmaceuticals | 9/5/2025 | Boost Price Target | $14.99 | $36.00 | Buy | $0.00 00.00% ROI | |
ANVS Annovis Bio | 9/3/2025 | Lower Price Target | $2.35 | $10.00 | Buy | $0.00 00.00% ROI | |
EBS Emergent Biosolutions | 9/3/2025 | Reiterated Rating | $8.23 | $15.00 | Buy | $0.00 00.00% ROI | |
RGEN Repligen | 9/3/2025 | Reiterated Rating | $120.69 | $180.00 | Buy | $0.00 00.00% ROI | |
PCSA Heatwurx | 9/2/2025 | Lower Price Target | $4.73 | $25.00 | Buy | $0.00 00.00% ROI | |
ENLV Enlivex Therapeutics | 9/2/2025 | Reiterated Rating | $15.75 | $105.00 | Buy | $0.00 00.00% ROI | |
BBIO BridgeBio Pharma | 8/29/2025 | Boost Price Target | $51.26 | $70.00 | Buy | $0.00 00.00% ROI | |
BTAI BioXcel Therapeutics | 8/28/2025 | Reiterated Rating | $3.96 | $10.00 | Buy | $0.00 00.00% ROI | |
COYA Coya Therapeutics | 8/25/2025 | Reiterated Rating | $6.86 | $18.00 | Buy | $0.00 00.00% ROI | |
BWAY Brainsway | 8/25/2025 | Reiterated Rating | $7.60 | $8.50 | Buy | $0.00 00.00% ROI | |
AVXL Anavex Life Sciences | 8/22/2025 | Reiterated Rating | $9.55 | $42.00 | Buy | $0.00 00.00% ROI | |
VNDA Vanda Pharmaceuticals | 8/21/2025 | Reiterated Rating | $4.60 | $20.00 | Buy | $0.00 00.00% ROI | |
SEPN Septerna | 8/21/2025 | Reiterated Rating | $11.12 | $26.00 | Buy | $0.00 00.00% ROI | |
FENC Adherex Technologies | 8/21/2025 | Reiterated Rating | $8.17 | $13.00 | Buy | $0.00 00.00% ROI | |
SLNO Soleno Therapeutics | 8/18/2025 | Reiterated Rating | $71.63 | $110.00 | Buy | $0.00 00.00% ROI | |
ABEO Abeona Therapeutics | 8/18/2025 | Reiterated Rating | $7.13 | $20.00 | Buy | $0.00 00.00% ROI | |
GMAB Genmab A/S | 8/15/2025 | Boost Price Target | $22.98 | $36.00 | Buy | $00.00 00.00% ROI | |
BTAI BioXcel Therapeutics | 8/15/2025 | Boost Price Target | $4.97 | $10.00 | Buy | $0.00 00.00% ROI | |
BWAY Brainsway | 8/14/2025 | Boost Price Target | $6.35 | $8.50 | Buy | $00.00 00.00% ROI | |
INO Inovio Pharmaceuticals | 8/14/2025 | Reiterated Rating | $1.70 | $3.00 | Neutral | $0.00 00.00% ROI | |
ASRT Assertio | 8/12/2025 | Lower Price Target | $10.88 | $45.00 | Buy | $0.00 00.00% ROI | |
INVA Innoviva | 8/11/2025 | Boost Price Target | $18.34 | $45.00 | Buy | $00.00 00.00% ROI | |
NAGE Niagen Bioscience | 8/11/2025 | Boost Price Target | $9.73 | $12.00 | Buy | $0.00 00.00% ROI | |
URGN Urogen Pharma | 8/11/2025 | Lower Price Target | $17.75 | $40.00 | Buy | $00.00 00.00% ROI | |
AVDL Avadel Pharmaceuticals | 8/8/2025 | Reiterated Rating | $12.74 | $24.00 | Buy | $0.00 00.00% ROI | |
RYTM Rhythm Pharmaceuticals | 8/7/2025 | Boost Price Target | $90.01 | $100.00 | Buy | $000.00 00.00% ROI | |
BCPC Balchem | 8/4/2025 | Reiterated Rating | $152.17 | $189.00 | Buy | $000.00 00.00% ROI | |
RARE Ultragenyx Pharmaceutical | 7/28/2025 | Upgrade | $27.34 | $80.00 | Buy | $00.00 00.00% ROI | |
AVDL Avadel Pharmaceuticals | 7/18/2025 | Reiterated Rating | $10.84 | $22.00 | Buy | $0.00 00.00% ROI | |
KZR Kezar Life Sciences | 7/16/2025 | Reiterated Rating | $4.62 | | Neutral | $0.00 00.00% ROI | |
PMN Promis Neurosciences | 7/14/2025 | Initiated Coverage | $9.76 | $100.00 | Buy | $00.00 00.00% ROI | |
INVA Innoviva | 7/14/2025 | Initiated Coverage | $18.77 | $40.00 | Buy | $00.00 00.00% ROI | |
VRNA Verona Pharma PLC American Depositary Share | 7/14/2025 | Reiterated Rating | $104.83 | $107.00 | Neutral | $0.00 00.00% ROI | |
ABEO Abeona Therapeutics | 7/14/2025 | Reiterated Rating | $5.74 | $20.00 | Buy | $0.00 00.00% ROI | |
GANX Gain Therapeutics | 7/3/2025 | Reiterated Rating | $1.64 | $8.00 | Buy | $0.00 00.00% ROI | |
AARD Aardvark Therapeutics | 6/30/2025 | Initiated Coverage | $13.39 | $40.00 | Buy | $0.00 00.00% ROI | |
PCSA Heatwurx | 6/30/2025 | Lower Price Target | $4.91 | $50.00 | Buy | $0.00 00.00% ROI | |
CGTX Cognition Therapeutics | 6/26/2025 | Reiterated Rating | $0.30 | $3.00 | Buy | $0.00 00.00% ROI | |
SEPN Septerna | 6/23/2025 | Initiated Coverage | $10.47 | $26.00 | Buy | $00.00 00.00% ROI | |
COCP Cocrystal Pharma | 6/20/2025 | Lower Price Target | $1.55 | $6.00 | Buy | $0.00 00.00% ROI | |
AQST Aquestive Therapeutics | 6/17/2025 | Reiterated Rating | $3.54 | $10.00 | Buy | $0.00 00.00% ROI | |
OMER Omeros | 6/10/2025 | Initiated Coverage | $3.77 | $9.00 | Buy | $0.00 00.00% ROI | |
AXSM Axsome Therapeutics | 6/10/2025 | Reiterated Rating | $109.87 | $180.00 | Buy | $000.00 00.00% ROI | |
ANVS Annovis Bio | 6/9/2025 | Lower Price Target | $3.20 | $12.00 | Buy | $0.00 00.00% ROI | |
BBIO BridgeBio Pharma | 6/9/2025 | Boost Price Target | $38.62 | $56.00 | Buy | $00.00 00.00% ROI | |
BWAY Brainsway | 6/9/2025 | Reiterated Rating | $5.23 | $8.00 | Buy | $00.00 00.00% ROI | |
COYA Coya Therapeutics | 6/9/2025 | Reiterated Rating | $5.88 | $18.00 | Buy | $0.00 00.00% ROI | |
VRNA Verona Pharma PLC American Depositary Share | 6/2/2025 | Boost Price Target | $80.83 | $90.00 | Buy | $0.00 00.00% ROI | |
OVID Ovid Therapeutics | 5/27/2025 | Lower Price Target | $0.29 | $1.50 | Buy | $0.00 00.00% ROI | |
CGTX Cognition Therapeutics | 5/27/2025 | Lower Price Target | $0.30 | $3.00 | Buy | $0.00 00.00% ROI | |
URGN Urogen Pharma | 5/22/2025 | Downgrade | $4.17 | | Neutral | $00.00 00.00% ROI | |
AXSM Axsome Therapeutics | 5/22/2025 | Reiterated Rating | $105.76 | $180.00 | Buy | $000.00 00.00% ROI | |
FENC Adherex Technologies | 5/20/2025 | Reiterated Rating | $7.65 | $13.00 | Buy | $0.00 00.00% ROI | |
TRDA Entrada Therapeutics | 5/20/2025 | Reiterated Rating | $8.01 | $20.00 | Buy | $0.00 00.00% ROI | |
ASRT Assertio | 5/19/2025 | Reiterated Rating | $9.99 | $52.50 | Buy | $00.00 00.00% ROI | |
GANX Gain Therapeutics | 5/19/2025 | Reiterated Rating | $2.01 | $8.00 | Buy | $0.00 00.00% ROI | |
AQST Aquestive Therapeutics | 5/15/2025 | Reiterated Rating | $2.22 | $10.00 | Buy | $0.00 00.00% ROI | |
URGN Urogen Pharma | 5/13/2025 | Reiterated Rating | $11.14 | $55.00 | Buy | $00.00 00.00% ROI | |
AXSM Axsome Therapeutics | 5/7/2025 | Lower Price Target | $112.16 | $180.00 | Buy | $000.00 00.00% ROI | |
VNDA Vanda Pharmaceuticals | 5/7/2025 | Reiterated Rating | $4.37 | $20.00 | Buy | $0.00 00.00% ROI | |
VRNA Verona Pharma PLC American Depositary Share | 4/30/2025 | Boost Price Target | $73.21 | $85.00 | Buy | $0.00 00.00% ROI | |
ABEO Abeona Therapeutics | 4/30/2025 | Boost Price Target | $5.30 | $20.00 | Buy | $0.00 00.00% ROI | |
BCPC Balchem | 4/28/2025 | Set Price Target | $153.64 | $180.00 | Buy | $000.00 00.00% ROI | |
URGN Urogen Pharma | 4/28/2025 | Reiterated Rating | $9.87 | $55.00 | Buy | $00.00 00.00% ROI | |
BBIO BridgeBio Pharma | 4/15/2025 | Boost Price Target | $34.85 | $53.00 | Buy | $00.00 00.00% ROI | |
SLNO Soleno Therapeutics | 4/15/2025 | Reiterated Rating | $70.00 | $100.00 | Buy | $00.00 00.00% ROI | |
PYPD PolyPid | 4/14/2025 | Reiterated Rating | $2.54 | $11.00 | Buy | $0.00 00.00% ROI | |
MBOT Microbot Medical | 4/10/2025 | Reiterated Rating | $1.65 | $9.00 | Buy | $0.00 00.00% ROI | |
GMAB Genmab A/S | 4/9/2025 | Reiterated Rating | $17.98 | $37.00 | Buy | $00.00 00.00% ROI | |
RYTM Rhythm Pharmaceuticals | 4/8/2025 | Reiterated Rating | $54.96 | $80.00 | Buy | $00.00 00.00% ROI | |
AVXL Anavex Life Sciences | 4/7/2025 | Reiterated Rating | $8.19 | $42.00 | Buy | $0.00 00.00% ROI | |
AXSM Axsome Therapeutics | 4/3/2025 | Reiterated Rating | $109.75 | $200.00 | Buy | $000.00 00.00% ROI | |
AQST Aquestive Therapeutics | 4/2/2025 | Reiterated Rating | $2.86 | $10.00 | Buy | $0.00 00.00% ROI | |
TRDA Entrada Therapeutics | 3/31/2025 | Reiterated Rating | $9.56 | $20.00 | Buy | $00.00 00.00% ROI | |
AVXL Anavex Life Sciences | 3/31/2025 | Reiterated Rating | $8.72 | $42.00 | Buy | $0.00 00.00% ROI | |
SLNO Soleno Therapeutics | 3/31/2025 | Boost Price Target | $71.99 | $100.00 | Buy | $00.00 00.00% ROI | |
RMTI Rockwell Medical | 3/24/2025 | Lower Price Target | $13.50 | $30.00 | Buy | $00.00 00.00% ROI | |
ENLV Enlivex Therapeutics | 3/24/2025 | Boost Price Target | $15.68 | $105.00 | Buy | $00.00 00.00% ROI | |
CGTX Cognition Therapeutics | 3/24/2025 | Lower Price Target | $0.45 | $5.00 | Buy | $0.00 00.00% ROI | |
LGVN Longeveron | 3/21/2025 | Reiterated Rating | $1.76 | $10.00 | Buy | $0.00 00.00% ROI | |
ASRT Assertio | 3/19/2025 | Lower Price Target | $10.77 | $52.50 | Buy | $00.00 00.00% ROI | |
INO Inovio Pharmaceuticals | 3/19/2025 | Reiterated Rating | $2.10 | $3.00 | Neutral | $0.00 00.00% ROI | |
ACOG Alpha Cognition | 3/18/2025 | Initiated Coverage | $5.69 | $20.00 | Buy | $0.00 00.00% ROI | |
ENTX Entera Bio | 3/18/2025 | Reiterated Rating | $1.96 | $10.00 | Buy | $0.00 00.00% ROI | |
RGNX REGENXBIO | 3/17/2025 | Lower Price Target | $6.72 | $34.00 | Buy | $0.00 00.00% ROI | |
NAGE Niagen Bioscience | 3/17/2025 | Reiterated Rating | $7.84 | $11.00 | Buy | $0.00 00.00% ROI | |
GANX Gain Therapeutics | 3/17/2025 | Reiterated Rating | $2.11 | $8.00 | Buy | $0.00 00.00% ROI | |
BWAY Brainsway | 3/12/2025 | Reiterated Rating | $4.81 | $8.00 | Buy | $00.00 00.00% ROI | |
FENC Adherex Technologies | 3/11/2025 | Reiterated Rating | $6.11 | $13.00 | Buy | $0.00 00.00% ROI | |
URGN Urogen Pharma | 3/11/2025 | Lower Price Target | $9.92 | $55.00 | Buy | $00.00 00.00% ROI | |
AQST Aquestive Therapeutics | 3/10/2025 | Reiterated Rating | $2.65 | $10.00 | Buy | $0.00 00.00% ROI | |
NAGE Niagen Bioscience | 3/10/2025 | Boost Price Target | $7.70 | $11.00 | Buy | $0.00 00.00% ROI | |
AXSM Axsome Therapeutics | 3/6/2025 | Reiterated Rating | $125.10 | $200.00 | Buy | $000.00 00.00% ROI | |
CING Cingulate | 3/6/2025 | Reiterated Rating | $3.76 | $20.00 | Buy | $0.00 00.00% ROI | |
LGVN Longeveron | 3/3/2025 | Reiterated Rating | $1.52 | $10.00 | Buy | $0.00 00.00% ROI | |
VRNA Verona Pharma PLC American Depositary Share | 2/28/2025 | Boost Price Target | $67.12 | $75.00 | Buy | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 2/27/2025 | Reiterated Rating | $42.37 | $100.00 | Buy | $00.00 00.00% ROI | |
URGN Urogen Pharma | 2/25/2025 | Reiterated Rating | $9.74 | $64.00 | Buy | $00.00 00.00% ROI | |
TRDA Entrada Therapeutics | 2/25/2025 | Reiterated Rating | $12.85 | $20.00 | Buy | $00.00 00.00% ROI | |
BCPC Balchem | 2/24/2025 | Reiterated Rating | $163.72 | $190.00 | Buy | $000.00 00.00% ROI | |
AXSM Axsome Therapeutics | 2/20/2025 | Boost Price Target | $126.96 | $200.00 | Buy | $000.00 00.00% ROI | |
AVXL Anavex Life Sciences | 2/18/2025 | Reiterated Rating | $8.52 | $42.00 | Buy | $0.00 00.00% ROI | |
BBIO BridgeBio Pharma | 2/13/2025 | Reiterated Rating | $31.95 | $49.00 | Buy | $00.00 00.00% ROI | |
AXSM Axsome Therapeutics | 2/11/2025 | Reiterated Rating | $127.08 | $190.00 | Buy | $000.00 00.00% ROI | |
RANI Rani Therapeutics | 2/7/2025 | Reiterated Rating | $1.65 | $9.00 | Buy | $0.00 00.00% ROI | |
TRDA Entrada Therapeutics | 2/4/2025 | Reiterated Rating | $13.33 | $20.00 | Buy | $00.00 00.00% ROI | |
PLX Protalix BioTherapeutics | 2/3/2025 | Boost Price Target | $2.43 | $15.00 | Buy | $0.00 00.00% ROI | |
AXSM Axsome Therapeutics | 1/31/2025 | Boost Price Target | $108.85 | $190.00 | Buy | $000.00 00.00% ROI | |
CING Cingulate | 1/30/2025 | Boost Price Target | $4.74 | $20.00 | Buy | $0.00 00.00% ROI | |
SPRO Spero Therapeutics | 1/30/2025 | Reiterated Rating | $0.86 | $5.00 | Buy | $0.00 00.00% ROI | |
BTAI BioXcel Therapeutics | 1/30/2025 | Lower Price Target | $5.28 | $48.00 | Buy | $0.00 00.00% ROI | |
AVXL Anavex Life Sciences | 1/28/2025 | Reiterated Rating | $9.82 | $42.00 | Buy | $0.00 00.00% ROI | |
MBOT Microbot Medical | 1/24/2025 | Boost Price Target | $1.91 | $9.00 | Buy | $0.00 00.00% ROI | |
RKTO Rocket One Inc. Common Stock | 1/23/2025 | Reiterated Rating | $1.36 | $4.00 | Buy | $0.00 00.00% ROI | |
GMAB Genmab A/S | 1/23/2025 | Reiterated Rating | $20.97 | $50.00 | Buy | $00.00 00.00% ROI | |
RGEN Repligen | 1/23/2025 | Lower Price Target | $166.84 | $180.00 | Buy | $000.00 00.00% ROI | |
COCP Cocrystal Pharma | 1/22/2025 | Reiterated Rating | $1.96 | $7.00 | Buy | $0.00 00.00% ROI | |
RVPH Reviva Pharmaceuticals | 1/22/2025 | Lower Price Target | $40.00 | $220.00 | Buy | $0.00 00.00% ROI | |
VRNA Verona Pharma PLC American Depositary Share | 1/21/2025 | Reiterated Rating | $51.89 | $60.00 | Buy | $0.00 00.00% ROI | |
AVXL Anavex Life Sciences | 1/21/2025 | Reiterated Rating | $9.21 | $42.00 | Buy | $0.00 00.00% ROI | |
AXSM Axsome Therapeutics | 1/21/2025 | Reiterated Rating | $91.93 | $180.00 | Buy | $000.00 00.00% ROI | |
INO Inovio Pharmaceuticals | 1/13/2025 | Lower Price Target | $1.98 | $3.00 | Neutral | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 1/10/2025 | Reiterated Rating | $48.17 | $100.00 | Buy | $00.00 00.00% ROI | |